Eosinophilic fasciitis in an adolescent girl with lymphadenopathy and vitiligo-like and linear scleroderma-like changes. A case report.
The patient, a 14-year-old girl, suffered from arthralgias which occurred after tonsillitis. Two months later she developed edema of the left lower extremity, finger flexion contractures and induration of the skin of the left leg, associated with hypergammaglobulinemia, peripheral hypereosinophilia, elevated ESR and a positivity of ANA and anti ds-DNA antibodies. A biopsy of the inguinal lymph node, performed because of left inguinal and retroperitoneal lymphadenopathy, showed only slight inflammatory activation and a granulomatous reaction after lymphography. A few days after the lymphography linear erythema evolving later into hyperpigmentation and corresponding to the superficial lymphatics developed on the left side of the body, very probably as a reaction to the patent-blue dye. Deep en-block skin biopsy confirmed the diagnosis of eosinophilic fasciitis (EF). After two years of therapy with prednisone and d-penicillamine the patient felt well, and her flexion contractures resolved, ANA were positive, while anti ds-DNA were negative. Linear hyperpigmentation persisted, and linear scleroderma-like changes developed on the left lower limb. A vitiligo-like lesion on the right foot which occurred after one year of therapy persisted. The possible risk of developing systemic connective tissue disease necessitates the long term follow up of this patient.
Stork
J
J
Second Department of Dermatology, General Faculty Hospital, 1st Faculty of Medicine, Prague, Czech Republic.
Nĕmcová
D
D
Hoza
J
J
Kodetová
D
D
D000293:Adolescent; D000974:Antibodies, Antinuclear / Q000097:blood; D001323:Autoantibodies / Q000097:blood; D001706:Biopsy; D004802:Eosinophilia / Q000175:diagnosis* / Q000188:drug therapy; D005208:Fasciitis / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006101:Granuloma, Giant Cell / Q000473:pathology; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D012595:Scleroderma, Systemic / Q000175:diagnosis*; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000209:etiology / Q000473:pathology; D014820:Vitiligo / Q000175:diagnosis*
D000974:Antibodies, Antinuclear; D001323:Autoantibodies